Related Experiment Video
Updated: Aug 19, 2026

Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis
Published on: March 22, 2016
[Antiatherogenic actions of etidronate on atherosclerosis]
1Division of Endocrinology and Metabolism, Department of Internal Medicine, Hyogo Prefectural Amagasaki Hospital.
Abstract:
Bisphosphonates including etidronate have been suggested to have antiatherogenic actions in experimental animals or in vitro. However, there has been no report indicating that bisphosphonates have antiatherogenic actions in humans. We have recently reported that etidronate, one of the bisphosphonates, decreased the intima-media thickness in subjects with type 2 diabetes, indicating a possibility that etidronate may have antiatherogenic action in humans.
Related Concept Videos
Atherosclerosis III: Management
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Atherosclerosis I: Introduction
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis IV: Nursing Management
